Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Korro Bio granted non-statutory stock options to purchase 4,000 aggregate shares to two newly hired employees as employment inducements. The options carry a $8.88 exercise price equal to the October 14, 2026 Nasdaq closing price, with a ten-year term and four-year vesting including a one-year cliff.
Key figures
- Vesting years
- 4
- Exercise price
- 8.88
- Shares granted
- 4000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.